NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company11 Sept 2026 · 11 Sept 2026, 04:02 pm

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Max Healthcare Institute Limited · MAXHEALTH

✦ AI SummaryLitigation

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding pendency of litigation against its subsidiary Kalinga Hospital Ltd.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

MAXHEALTH_11092026160125_SE_Disclosure_Kalinga_Hearing.pdf

pdf

Download →
View document text
September 11, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 Symbol: MAXHEALTH Scrip Code: 543220 Sub.: Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, This is in continuation to our earlier intimation dated August 19, 2026 regarding petitions, including interlocutory petition, filed before the Hon'ble National Company Law Tribunal, Cuttack Bench (“NCLT”) by the legal representatives of BRS Capital Two Pte. Limited (“BRS Capital”) against Kalinga Hospital Ltd. ("KHL"), a subsidiary of the Company, the other shareholder of KHL from whom the Company acquired the majority equity stake and the Company. In addition to above, the legal representatives of BRS Capital filed further interlocutory petitions before the Hon’ble NCLT seeking certain interim reliefs. The said petitions were listed for hearing on September 8, 2026 at 3.00 pm (IST). Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure Details with respect to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Particulars Details 1. The details of any change in the status and The matter was heard by the Hon’ble National Company Law / or any development in relation to such Tribunal, Cuttack Bench (“NCLT”) on September 8, 2026 and proceedings directed the Respondents including the Company to file reply, if any, within one week. The next date of the hearing is September 28, 2026. The Company received a copy of the order passed by the Hon'ble NCLT on September 10, 2026 at 4.42 pm (IST). 2. In the case of litigation against key Not applicable management personnel or its promoter or ultimate person in control, regularly provide details of any in the status and / or any development in relation to such proceedings 3. In the event of settlement of the Not applicable proceedings, details of such settlement including - terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity